Because high expression of Brf1 is associated with shorter overall survival period (Figure 2 and Supplementary Figure S1), this implies that the human HCC cases with high expression of Brf1 have a poorer prognosis. The gene discussed is BRF1; the disease is hepatocellular carcinoma.